| | | | | | | | | | |
|
|
| Dockets Entered
On April 21, 2005
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1979N-0113
|
| Parenteral Multivitamin Products
|
|
|
| 2004D-0041
|
| Guidance for Industry on Providing Regulatory Submissions in Electronic Format--Content of Labeling
|
|
|
| 2004D-0410
|
| Application User Fees for Combination Products
|
|
|
| 2004N-0456
|
| Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
|
|
|
|
|
|
| 2004N-0463
|
| Food Labeling: Prominence of Calories
|
|
|
| 2004N-0469
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General Records
|
|
|
| 2004N-0470
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| 2004N-0486
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Experimental Study of Health Claims on Food Packages
|
|
|
| 2005D-0122
|
| Guidance for Industry on Exploratory IND Studies
|
|
|
| 2005D-0133
|
| Guidance for Industry: Assessing Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection
|
|
|
| 2005N-0059
|
| Withdrawal of Approval of a New Animal Drug Application; Dichlorophene and Toluene Capsules
|
|
|
| 2005N-0119
|
| Preparation for the International Conference on Harmonization Meetings in Brussels, Belgium: Public Meeting
|
|
|
| 2005N-0123
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Survey of Need for Online Medical Device Information
|
|
|
| 2005N-0137
|
| Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
|
|
|
| 1979N-0113
|
| Parenteral Multivitamin Products
|
|
|
| N
5
|
| FDA
|
| Vol #:
|
| 5
|
|
|
| 2004D-0041
|
| Guidance for Industry on Providing Regulatory Submissions in Electronic Format--Content of Labeling
|
|
|
| GDL
2
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004D-0410
|
| Application User Fees for Combination Products
|
|
|
| GDL
2
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0456
|
| Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
|
|
|
|
|
|
| C 20
|
| O. T. Marchant
|
| Vol #:
|
| 1
|
|
|
| C 21
|
| J. I. Appel
|
| Vol #:
|
| 1
|
|
|
| C 22
|
| T. Hammer
|
| Vol #:
|
| 1
|
|
|
| C 23
|
| K. Olson
|
| Vol #:
|
| 1
|
|
|
| C 24
|
| I. G. Buirrhatter
|
| Vol #:
|
| 1
|
|
|
| C 25
|
| D. Douglass
|
| Vol #:
|
| 4
|
|
|
| C 26
|
| M. S. Patterson
|
| Vol #:
|
| 1
|
|
|
| C 27
|
| D. A. Maller
|
| Vol #:
|
| 1
|
|
|
| C 28
|
| J. C. Groen
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2004N-0486
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Experimental Study of Health Claims on Food Packages
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005D-0122
|
| Guidance for Industry on Exploratory IND Studies
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005D-0133
|
| Guidance for Industry: Assessing Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection
|
|
|
| BKG
1
|
| Refs 1 -13 found in 70FR20575
|
| Vol #:
|
| 2
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005N-0059
|
| Withdrawal of Approval of a New Animal Drug Application; Dichlorophene and Toluene Capsules
|
|
|
| LET 1
|
| HFA-305 to Natchez Animal Supply Co
|
| Vol #:
|
| 1
|
|
|
| 2005N-0119
|
| Preparation for the International Conference on Harmonization Meetings in Brussels, Belgium: Public Meeting
|
|
|
| NM
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005N-0123
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Survey of Need for Online Medical Device Information
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005N-0137
|
| Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
|
|
|
| NM
1
|
| FDA
|
| Vol #:
|
| 1
|
|